Recruiting NA Essential Tremor

New treatment option for Essential Tremor

Official title Electroclinical Correlates in Essential Tremor

ClinicalTrials.gov ID: NCT05671848

What this study is testing

What it's testing
Essential tremor (ET) is a neurological disorder that affects nearly 0.9% of the world's population. High-frequency Deep Brain Stimulation (DBS) of the ventral-intermediate nuclei of the thalamus (VIM) has been proven as an effective second-line treatment for severe forms of ET.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 75

You may be able to join if

  • Advanced disabling and drug-resistant tremor
  • Receiving deep brain stimulation treatment with implantation of the PERCEPT™ device according to standard care
  • Chronic progressive cardiac, renal, hematological or pulmonary diseases under treatment.
  • Patient aged between 18 to 75 years
  • Normal brain MRI

You likely can't join if

  • Major depressive syndrome (Beck scale \> 20)
  • MRI showing significant brain atrophy or significant hypersignals
  • Pregnant or breastfeeding women
  • Being unable to give personal consent
  • Be subject to a measure of legal protection (curatorship, guardianship) or placed under judicial protection.
See the full eligibility criteria
Who can join
  • Advanced disabling and drug-resistant tremor
  • Receiving deep brain stimulation treatment with implantation of the PERCEPT™ device according to standard care
  • Chronic progressive cardiac, renal, hematological or pulmonary diseases under treatment.
  • Patient aged between 18 to 75 years
  • Normal brain MRI
  • MATTIS score ≥ 130/144 or MOCA ≥ 24/30
  • Subject affiliated with or benefiting from a social security plan
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research)
What rules you out
  • Major depressive syndrome (Beck scale \> 20)
  • MRI showing significant brain atrophy or significant hypersignals
  • Pregnant or breastfeeding women
  • Being unable to give personal consent
  • Be subject to a measure of legal protection (curatorship, guardianship) or placed under judicial protection.

The study team makes the final eligibility decision.

Where it's taking place

  • Bordeaux, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Bordeaux, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.